THURSDAY, Nov. 14, 2019 -- People with peanut allergy must be constantly vigilant to avoid a life-threatening allergic reaction. But researchers report that a new drug injection might offer at least temporary protection against the most severe reactions.
Just one shot of an experimental antibody treatment allowed people with severe peanut allergy to eat about one peanut's worth of peanut protein two weeks later, the study found.
MONDAY, Oct. 21, 2019 -- One consequence of the government's limited role in regulating cosmetics is that questionable products may stay on store shelves and e-commerce sites despite complaints. Even when consumers report problems, the U.S. Food and Drug Administration can't issue a recall -- it can only recommend one.
Also, the FDA doesn't require cosmetics companies to tell it about consumer complaints, and people who experience problems may not realize that they should contact the FDA as well as the cosmetics company. This explains how one manufacturer received 21,000 direct complaints about a hair care product, yet the FDA got only a fraction of that number.
MONDAY, Oct. 28, 2019 -- Giving antihistamines to a child suffering a potentially fatal allergic reaction may do more harm than good if it causes a delay in emergency treatment, a new study warns.
Researchers reviewed the medical records of young patients, aged 8 months to 20 years, who were admitted to a pediatric intensive care unit for treatment of anaphylaxis between July 2015 and January 2019.
WEDNESDAY, Oct. 2, 2019 -- As the number of cases and deaths tied to vaping-linked lung injury continues to rise across the United States, a meticulous examination of 17 such cases suggests a possible culprit.
All of the patients examined had severe forms of the illness, and two had died.